These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 34248988)

  • 1. Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer.
    Luo X; Xu J; Yu J; Yi P
    Front Immunol; 2021; 12():692360. PubMed ID: 34248988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophage-targeted therapeutics in ovarian cancer.
    An Y; Yang Q
    Int J Cancer; 2021 Jul; 149(1):21-30. PubMed ID: 33231290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor associated macrophages in the molecular pathogenesis of ovarian cancer.
    Yousefzadeh Y; Hallaj S; Baghi Moornani M; Asghary A; Azizi G; Hojjat-Farsangi M; Ghalamfarsa G; Jadidi-Niaragh F
    Int Immunopharmacol; 2020 Jul; 84():106471. PubMed ID: 32305830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.
    Ardighieri L; Missale F; Bugatti M; Gatta LB; Pezzali I; Monti M; Gottardi S; Zanotti L; Bignotti E; Ravaggi A; Tognon G; Odicino F; Calza S; Missolo-Koussou Y; Ries CH; Helft J; Vermi W
    Front Immunol; 2021; 12():690201. PubMed ID: 34220848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer.
    Wilkinson K; Ng W; Roberts TL; Becker TM; Lim SH; Chua W; Lee CS
    J Clin Pathol; 2021 Oct; 74(10):625-634. PubMed ID: 33753562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor infiltrating lymphocytes in ovarian cancer.
    Santoiemma PP; Powell DJ
    Cancer Biol Ther; 2015; 16(6):807-20. PubMed ID: 25894333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment.
    Liu K; Huang A; Nie J; Tan J; Xing S; Qu Y; Jiang K
    Front Immunol; 2021; 12():683332. PubMed ID: 34093586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.
    Xing Y; Ruan G; Ni H; Qin H; Chen S; Gu X; Shang J; Zhou Y; Tao X; Zheng L
    Front Immunol; 2021; 12():624725. PubMed ID: 34084160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
    Nascimento C; Ferreira F
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication.
    De Nola R; Menga A; Castegna A; Loizzi V; Ranieri G; Cicinelli E; Cormio G
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.
    Nagpal P; Descalzi-Montoya DB; Lodhi N
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian Cancer Immunotherapy: Turning up the Heat.
    Ghisoni E; Imbimbo M; Zimmermann S; Valabrega G
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue.
    Das K; Urbiola C; Spiesschaert B; Mueller P; Wollmann G
    Methods Mol Biol; 2020; 2058():155-177. PubMed ID: 31486037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of the immune microenvironment in ovarian cancer patients.
    Yang L; Wang S; Zhang Q; Pan Y; Lv Y; Chen X; Zuo Y; Hao D
    Mol Omics; 2018 Oct; 14(5):341-351. PubMed ID: 30129640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity.
    Santos JM; Heiniö C; Cervera-Carrascon V; Quixabeira DCA; Siurala M; Havunen R; Butzow R; Zafar S; de Gruijl T; Lassus H; Kanerva A; Hemminki A
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31940588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer.
    Zhang J; Zhang J; Wang F; Xu X; Li X; Guan W; Men T; Xu G
    J Cell Physiol; 2021 Oct; 236(10):6907-6919. PubMed ID: 33655494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment.
    Zhang J; Song C; Tian Y; Yang X
    Front Immunol; 2021; 12():802080. PubMed ID: 35126365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells.
    Jiang L; Fang X; Wang H; Li D; Wang X
    Front Immunol; 2018; 9():2927. PubMed ID: 30619288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas.
    Chen R; Wang X; Dai Z; Wang Z; Wu W; Hu Z; Zhang X; Liu Z; Zhang H; Cheng Q
    Front Immunol; 2021; 12():713757. PubMed ID: 34712225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.